Literature DB >> 15017127

Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway).

Trude Eid Robsahm1, Steinar Tretli, Arne Dahlback, Johan Moan.   

Abstract

OBJECTIVE: To investigate whether prognosis of breast-, colon- and prostate cancer may be related to vitamin D(3), induced from solar ultra-violet (UV) radiation, through studies on geographical and seasonal variations in UV radiation.
METHODS: This study includes 115,096 cases of breast-, colon- or prostate cancer, diagnosed between 1964 and 1992. Among these, 45,667 deaths due to the cancer were registered. On the basis of a north-south gradient in solar UV radiation and geographical climatic differences, Norway was divided into eight residential regions. According to seasonal variations in UV radiation, four periods of diagnosis during the year were used. Case fatality according to residential region and to season of diagnosis was estimated using Cox regression. The effects of occupational sun exposure, childbearing pattern and educational level were also evaluated.
RESULTS: No geographic variation in case fatality was observed for the three cancer types studied. A significant variation in prognosis by season of diagnosis was observed. Diagnoses during summer and fall, the seasons with the highest level of vitamin D(3), revealed the lowest risk of cancer death.
CONCLUSION: The results suggest that a high level of vitamin D(3) at the time of diagnosis, and thus, during cancer treatment, may improve prognosis of the three cancer types studied.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15017127     DOI: 10.1023/B:CACO.0000019494.34403.09

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  79 in total

1.  Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients.

Authors:  François Meyer; Geoffrey Liu; Pierre Douville; Elodie Samson; Wei Xu; Araba Adjei; Isabelle Bairati
Journal:  Int J Cancer       Date:  2010-06-07       Impact factor: 7.396

Review 2.  Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review.

Authors:  Consuelo Buttigliero; Chiara Monagheddu; Paola Petroni; Andrea Saini; Luigi Dogliotti; Giovannino Ciccone; Alfredo Berruti
Journal:  Oncologist       Date:  2011-08-11

3.  Low 25-hydroxyvitamin D levels in people with a solid tumor cancer diagnosis: the tip of the iceberg?

Authors:  Katherine Hauser; Declan Walsh; Shiva Shrotriya; Matthew Karafa
Journal:  Support Care Cancer       Date:  2014-02-28       Impact factor: 3.603

4.  EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer.

Authors:  Erin L Milliken; Xiaoxue Zhang; Chris Flask; Jeffrey L Duerk; Paul N MacDonald; Ruth A Keri
Journal:  Cancer Lett       Date:  2005-08-22       Impact factor: 8.679

5.  Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741.

Authors:  Kimmie Ng; Daniel J Sargent; Richard M Goldberg; Jeffrey A Meyerhardt; Erin M Green; Henry C Pitot; Bruce W Hollis; Michael N Pollak; Charles S Fuchs
Journal:  J Clin Oncol       Date:  2011-03-21       Impact factor: 44.544

6.  Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells.

Authors:  Erik J Tokar; Mukta M Webber
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

7.  Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells.

Authors:  Erik J Tokar; Mukta M Webber
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

8.  Duration of vitamin D synthesis from weather model data for use in prospective epidemiological studies.

Authors:  Kåre Edvardsen; Ola Engelsen; Magritt Brustad
Journal:  Int J Biometeorol       Date:  2009-05-15       Impact factor: 3.787

9.  Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis.

Authors:  Rebecca Gilbert; Chris Metcalfe; Steven E Oliver; David C Whiteman; Chris Bain; Andy Ness; Jenny Donovan; Freddie Hamdy; David E Neal; J Athene Lane; Richard M Martin
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

Review 10.  Benefit-risk assessment of vitamin D supplementation.

Authors:  H A Bischoff-Ferrari; A Shao; B Dawson-Hughes; J Hathcock; E Giovannucci; W C Willett
Journal:  Osteoporos Int       Date:  2009-12-03       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.